Progress on Strategic Repositioning; Performance in Line with Expectations; Upgrading Performance Rating; Maintaining Price Target of ~$7.50.
DHC reported 21Q2 normalized funds from operations (FFO) of $12.2 million or $0.05 per share, lower than 20Q2’s $0.25, due mostly to a 780 bp decline in senior housing operating portfolio (SHOP) occupancy. Although SHOP occupancy was down vs. the prior year, it increased 140 bp sequentially, suggesting that a bottom is in. Still, the pace of the rebound is uncertain due to the Delta variant, among other factors. DHC’s office portfolio also reported a drop in profits mostly due to previous asset sales and a 100 bp decline in occupancy. However, strong lease-ups and the added contribution from redevelopment projects should improve its profitability going forward.
In April, DHC announced its plan to transition to other operators 108 smaller senior living communities that are currently managed by its affiliate Five Star Senior Living (FVE) and located mostly in the Southeast. In June, it announced signed agreements for 76 of those properties with three regional operators. 41 of the 76 had been transferred as of August 3. Although DHC has not disclosed the terms of these new arrangements, it expect to see meaningful improvements in occupancy at the 108 properties over time.
On March 31, DHC drew down its entire $800 million credit facility to ensure its liquidity in anticipation that it would violate the minimum debt service coverage requirement of 1.5 times. That followed a two-notch credit rating downgrade by Moody’s and a one-notch downgrade by S&P in February.
The end game, as I see it, remains the repayment/refinancing of the $1 billion 9.75% Senior Notes as soon as possible after the issue becomes callable in 2022. This could be accomplished through a combination of new equity and debt issuance, the proceeds of which would be used to repay the 9.75s. Raising new equity capital will require meaningful progress on building back SHOP occupancy. Although DHC’s occupancy seems to have bottomed out one quarter ahead of my expectations, there is still considerable uncertainty about whether and when the industry will return to pre-COVID occupancy levels. Nevertheless, I am maintaining my price target of ~$7.50 and raising my performance rating on the stock a notch to “1” (strong outperformance), given the stock’s decline year-to-date.
This is a summary of my update report on DHC dated August 18, 2021. To obtain a copy of the report, give me a call.
August 20, 2021
Stephen P. Percoco
839 Dewitt Street
Linden, New Jersey 07036
© 2015-2024 by Stephen P. Percoco, Lark Research. All rights reserved.
This blog post (as with all posts on this website) represents the opinion of Lark Research based upon its own independent research and supporting information obtained from various sources. Although Lark Research believes these sources to be reliable, it has not independently confirmed their accuracy. Consequently, this blog post may contain errors and omissions. Furthermore, this blog post is a summary of a recent report published on this subject and that report provides a more complete discussion and assessment of the risks and opportunities of any investment securities discussed herein. No representation or warranty is expressed or implied by the publication of this blog post. This blog post is for informational purposes only and shall not be construed as investment advice that meets the specific needs of any investor. Investors should, in consultation with their financial advisers, determine the suitability of the post’s recommendations, if any, to their own specific circumstances. Lark Research is not registered as an investment adviser with the Securities and Exchange Commission, pursuant to exemptions provided in the Investment Company Act of 1940. This blog post remains the property of Lark Research and may not be reproduced, copied or similarly disseminated, in whole or in part, without its prior written consent.